The poster titled "Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Culture” which is the joint working of Nanotehcnology and Biomaterial Research and Implementation Center, Medical Biochemistry and Şükran Karabelli Radiobiology Laboratoire, was awarded the second prize  in the “2nd International Cell Death Research Congress” that was attended by from all over the world.